1-3 of 3
Spencer Bruce Gibson, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ibrutinib in Combination with Venetoclax Decreases Mitochondrial Bioenergetics through the Impaired BTK, AKT and AMPK/SIRT/PGC-1α Signaling Pathway in CLL

Subir Roy Chowdhury, MD PhD, Amandeep Singh, MSc, Edwin Nguyen, Aaron Marshall, PhD, James B. Johnston, MD, Spencer Bruce Gibson, PhD, Versha Banerji, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1282.
https://doi.org/10.1182/blood-2019-127562
Published: 2019
Journal Articles

Venetoclax in Combination with NAMPT Inhibitors Decreases Mitochondrial Bioenergetics through the Impaired AMPK/SIRT/PGC1α Signaling Pathway in CLL

Subir Roy Chowdhury, MD PhD, Saleh Ryan, BSc, Cheryl Peltier, BSc, Mandy Squires, CCRP, HIT, Donna Hewitt, R.N., Paul Fernyhough, PhD, Spencer Bruce Gibson, PhD, Versha Banerji, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1368.
https://doi.org/10.1182/blood-2018-99-112210
Published: 2018
Journal Articles

A Descriptive Analysis of Obinutuzumab Usage in a Single Canadian Centre

Nicole Bourrier, BSc, Ivan Landego, MD, Mandy Squires, CCRP, HIT, Oliver Bucher, Zeb Aurangzeb, Erin Streu, MSN, RN, CON (C), Theresa Whiteside, RN, BN, CON (C), Irena Hibbert, RN, BN, CON (C), Marc Geirnaert, BSc Pharm, David Dawe, MD FRCPC, Spencer Bruce Gibson, PhD, James B. Johnston, MD FRCP, Versha Banerji, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5838.
https://doi.org/10.1182/blood-2018-99-113422
Published: 2018